The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

Overview of attention for article published in Osteoporosis International, September 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 79 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Bisphosphonate Drugs for the Treatment of Osteoporosis in Post-Menopausal Women

Cited by Canadian Agency for Drugs and Technologies in Health on 01 Jun 2021

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.